These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28718236)

  • 21. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
    Ferrannini E; Fonseca V; Zinman B; Matthews D; Ahrén B; Byiers S; Shao Q; Dejager S
    Diabetes Obes Metab; 2009 Feb; 11(2):157-66. PubMed ID: 19125777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
    Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
    Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison on efficacy and safety of two regimens for treatment of type 2 diabetes mellitus: glargine plus metformin versus neutral protamine hagedorn plus metformin].
    Hu M; Luo Y; Zhang L; Yang X; Zhang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Jun; 27(3):622-5. PubMed ID: 20649032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin treatment and gastrointestinal symptoms in youth: Findings from a large tertiary care referral center.
    Meyers AG; Hudson J; Cravalho CKL; Matta ST; Villalobos-Perez A; Cogen F; Chung ST
    Pediatr Diabetes; 2021 Mar; 22(2):182-191. PubMed ID: 33179823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone: a multicenter, randomized, controlled trial.
    Cai XL; Chen YL; Zhao JJ; Shan ZY; Qiu MC; Li CJ; Gu W; Tian HM; Yang HZ; Xue YM; Yang JK; Hong TP; Ji LN
    Chin Med J (Engl); 2015 May; 128(10):1279-87. PubMed ID: 25963345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study.
    Hermans MP; Delibasi T; Farmer I; Lohm L; Maheux P; Piatti P; Malvolti E; Jörgens S; Charbonnel B
    Curr Med Res Opin; 2012 Oct; 28(10):1635-45. PubMed ID: 23020253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiologic Surveillance of Glycemic Response to a Scored, Breakable, Extended Release, Fixed Dose Combination of Gliclazide and Metformin in Persons with Type 2 Diabetes.
    Kalra S; Das AK
    J Assoc Physicians India; 2017 Jun; 65(6):38-41. PubMed ID: 28782312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis.
    Tarry-Adkins JL; Grant ID; Ozanne SE; Reynolds RM; Aiken CE
    Diabetes Ther; 2021 Jul; 12(7):1901-1914. PubMed ID: 34075573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility trial of metformin XR in people with pre-diabetes and stroke (MIPPS)-randomised open blinded endpoint controlled trial.
    Tabesh M; Hachem M; Lau LH; Borschmann K; Churilov L; Price SAL; Sumithran P; Donnan G; Zajac J; Thijs V; Ekinci EI
    J Clin Neurosci; 2021 Apr; 86():103-109. PubMed ID: 33775312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.
    Schernthaner G; Matthews DR; Charbonnel B; Hanefeld M; Brunetti P;
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6068-76. PubMed ID: 15579760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin extended-release versus metformin immediate-release for adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
    Abrilla AA; Pajes ANNI; Jimeno CA
    Diabetes Res Clin Pract; 2021 Aug; 178():108824. PubMed ID: 33887354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended-release metformin hydrochloride. Single-composition osmotic tablet formulation.
    Wagstaff AJ; Figgitt DP
    Treat Endocrinol; 2004; 3(5):327-32. PubMed ID: 15330682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin extended release for the treatment of type 2 diabetes mellitus.
    Schwartz SL; Wu JF; Berner B
    Expert Opin Pharmacother; 2006 Apr; 7(6):803-9. PubMed ID: 16556094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study.
    Donnelly LA; Morris AD; Pearson ER
    Diabetes Obes Metab; 2009 Apr; 11(4):338-42. PubMed ID: 19267712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes.
    Yuxin H; Cuiping J; Wen T; Jieyuzhen Q; Xiaoming T; Qin G; Haidong W; Jiao S; Zhijun B
    J Clin Pharm Ther; 2020 Jun; 45(3):470-476. PubMed ID: 31769886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels.
    Burton JH; Johnson M; Johnson J; Hsia DS; Greenway FL; Heiman ML
    J Diabetes Sci Technol; 2015 Jul; 9(4):808-14. PubMed ID: 25802471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.
    Duong JK; Kumar SS; Kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR; Williams KM; Day RO
    Clin Pharmacokinet; 2013 May; 52(5):373-84. PubMed ID: 23475568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus.
    Levy J; Cobas RA; Gomes MB
    Diabetol Metab Syndr; 2010 Mar; 2():16. PubMed ID: 20298568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glumetza offers once-a-day dosing for type 2 diabetes patients.
    Laustsen G
    Nurse Pract; 2005 Nov; 30(11):68-9. PubMed ID: 16276309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.